Our results were not consistent with Zekri et al. [20] and Tovey et al. [45], who showed that IL-6 was slightly higher only in asymptomatic HCV carriers than controls but apparently normal in both HCC and chronic liver disease (CLD) patients. Here, IL6 is linked to hepatocellular carcinoma.